Regn news: the klein law firm initiates an investigation involving possible securities fraud violations by officers of regeneron pharmaceuticals, inc.

New york , july 11, 2023 /prnewswire/ -- the klein law firm announces that it is investigating allegations that regeneron pharmaceuticals, inc. ("regeneron") (nasdaq: regn) violated federal securities laws. current investigation details:the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
REGN Ratings Summary
REGN Quant Ranking